US FDA Still Not Scheduling In-Person Meetings Despite Sponsor Requests

 
• By Derrick Gingery

Some sponsors appear to be growing antsy to meet with agency staff and advisory committees in-person, but CDER continues to schedule only virtual meetings.

FDA not having in-person meetings
Some stakeholders are growing inpatient for the FDA to resume in-person meetings. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from US FDA Performance Tracker

More from Regulatory Trackers